Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Thierry O Fischman"'
Autor:
Thierry O Fischman, Petia A. Shipkova, Ronald Mierzwa, Samantha Bohanon, Cynthia Kravec, Mahesh Patel, Alan Hruza, Ling Xu, Lata Ramanathan, Joseph Terracciano, Frank Gentile, Ling He, Min Chu, C A Cramer, Tze-Ming Chan, Lynn Miesel
Publikováno v:
Tetrahedron Letters. 42:3549-3551
Sch 382582 ( 1 ) and Sch 382583 ( 2 ), two novel pseudopeptides, were isolated from fermentation broth of Streptomyces sp. as bacteria peptide deformylase inhibitors. Structure elucidation of 1 and 2 was accomplished by extensive 2D NMR spectroscopic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78ac38ae9e06d13ef261cd1f2281d5d2
https://doi.org/10.1016/s0040-4039(01)00525-1
https://doi.org/10.1016/s0040-4039(01)00525-1
Autor:
David Rosen, Laurence Fayadat-Dilman, Yiwei Zhang, Konstantin Dobrenkov, Elliot Chartash, Richard Wnek, Smita Mauze, Hans van Eenennaam, Judith Stammen-Vogelzangs, Ying Yu, Marco Guadagnoli, Lars Guelen, Thierry O Fischmann, Jerelyn Wong, Nikolina Bąbała, Jozef Wagenaars, Veronica Juan, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Sean Troth, Svetlana Sadekova, Andrea van Elsas, Jason K Cheung, Jannie Borst, Amy M Beebe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Immune checkpoint inhibitors (ICI) have radically changed cancer therapy, but most patients with cancer are unresponsive or relapse after treatment. MK-5890 is a CD27 agonist antibody intended to complement ICI therapy. CD27 is a member of
Externí odkaz:
https://doaj.org/article/cc59fd0a12e04837b4168ce751ae8a2b